The segregation of the motor phenotypes would be an important step towards the optimization of treatment interventions, including pharmacotherapy (e.g., administration of alpha-2 agonists for the treatment of milder tics and antidopaminergic agents for more severe tics). This evidence concerns the gene PSMA2 and Tics.